AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, T.
Right arrow Articles by Nakamura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, T.
Right arrow Articles by Nakamura, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Small Hypervascular Hepatocellular Carcinoma Revealed by Double Arterial Phase CT Performed with Single Breath-Hold Scanning and Automatic Bolus Tracking

Tonsok Kim1, Takamichi Murakami1, Masatoshi Hori1, Manabu Takamura1, Satoru Takahashi1, Atsuya Okada1, Shuji Kawata1, Modesto Cruz1, Michael P. Federle2 and Hironobu Nakamura1

1 Department of Radiology, D1 Osaka University Medical School, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan.
2 Department of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, 200 Lothrop St., Pittsburgh, PA 15213.



View larger version (16K):

[in a new window]
 
Fig. 1. Time chart for automatic bolus-tracking technique. Real-time low-dose serial monitor scans were automatically initiated 10 sec after start of injection of contrast material. CT values of region of interest specified in abdominal aorta were automatically calculated. Trigger for start of diagnostic scan was set at increase in aortic enhancement of 50H, and first arterial phase helical CT scan started automatically 10 sec after trigger level had been reached.

 


View larger version (18K):

[in a new window]
 
Fig. 2. Bar graph shows distribution of time elapsed until triggering. Time from initiation of contrast injection until trigger value had been reached varied from 10 to 23 sec. Mean time until triggering was 13 sec, but interval of 10 sec occurred in largest number of patients.

 


View larger version (128K):

[in a new window]
 
Fig. 3A. Hypervascular hepatocellular carcinoma lesion in 59-year-old woman. Rate of contrast injection was 5 mL/sec, and time elapsed until triggering was 10 sec. First arterial phase CT scan, started 20 sec after start of injection, shows hepatocellular carcinoma nodule (arrow) as hyperenhanced lesion.

 


View larger version (137K):

[in a new window]
 
Fig. 3B. Hypervascular hepatocellular carcinoma lesion in 59-year-old woman. Rate of contrast injection was 5 mL/sec, and time elapsed until triggering was 10 sec. Second arterial phase CT scan, started 38 sec after start of injection, fails to show hepatocellular carcinoma nodule.

 


View larger version (136K):

[in a new window]
 
Fig. 3C. Hypervascular hepatocellular carcinoma lesion in 59-year-old woman. Rate of contrast injection was 5 mL/sec, and time elapsed until triggering was 10 sec. Late phase CT scan fails to show hepatocellular carcinoma nodule.

 


View larger version (138K):

[in a new window]
 
Fig. 3D. Hypervascular hepatocellular carcinoma lesion in 59-year-old woman. Rate of contrast injection was 5 mL/sec, and time elapsed until triggering was 10 sec. CT during arterial portography image obtained at time of angiography performed after IV contrast-enhanced CT shows hepatocellular carcinoma (arrow) as area of decreased perfusion.

 


View larger version (126K):

[in a new window]
 
Fig. 3E. Hypervascular hepatocellular carcinoma lesion in 59-year-old woman. Rate of contrast injection was 5 mL/sec, and time elapsed until triggering was 10 sec. CT hepatic arteriogram shows hepatocellular carcinoma (arrow) as hyperenhanced lesion, proving that hepatocellular carcinoma was hypervascular.

 


View larger version (104K):

[in a new window]
 
Fig. 4A. 80-year-old man with hypervascular hepatocellular carcinoma. Rate of contrast injection was 5 mL/sec, and time until triggering was 18 sec. First arterial phase CT scan, started 28 sec after start of contrast injection, shows hepatocellular carcinoma nodule (arrow) as slightly hyperenhanced lesion.

 


View larger version (107K):

[in a new window]
 
Fig. 4B. 80-year-old man with hypervascular hepatocellular carcinoma. Rate of contrast injection was 5 mL/sec, and time until triggering was 18 sec. Second arterial phase CT scan, started 46 sec after start of contrast injection, shows hepatocellular carcinoma as more prominently hyperenhanced lesion (arrow) than did first arterial phase CT.

 


View larger version (118K):

[in a new window]
 
Fig. 4C. 80-year-old man with hypervascular hepatocellular carcinoma. Rate of contrast injection was 5 mL/sec, and time until triggering was 18 sec. Late phase CT scan shows hepatocellular carcinoma (arrow) as slightly hypoenhanced lesion.

 


View larger version (135K):

[in a new window]
 
Fig. 4D. 80-year-old man with hypervascular hepatocellular carcinoma. Rate of contrast injection was 5 mL/sec, and time until triggering was 18 sec. CT during arterial portography scan obtained during angiography performed after IV contrast-enhanced CT shows hepatocellular carcinoma (arrow) as area of decreased perfusion.

 


View larger version (129K):

[in a new window]
 
Fig. 4E. 80-year-old man with hypervascular hepatocellular carcinoma. Rate of contrast injection was 5 mL/sec, and time until triggering was 18 sec. CT scan after intraarterial iodized oil injection shows hepatocellular carcinoma (arrow) as hyperenhanced lesion, proving hepatocellular carcinoma to be hypervascular.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.